Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000921895-25-002791·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Invivyd Inc
Common Stock, $0.0001 par value per share · CUSIP: 00534A102
Event date: 2025-10-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L P
Shares: 8,545,920.00 · Class: 4.0%
- BVF I GP LLC
Shares: 8,545,920.00 · Class: 4.0%
- BIOTECHNOLOGY VALUE FUND II LP
Shares: 6,211,464.00 · Class: 2.9%
- BVF II GP LLC
Shares: 6,211,464.00 · Class: 2.9%
- Biotechnology Value Trading Fund OS LP
Shares: 991,974.00 · Class: 0.5%
- BVF Partners OS Ltd.
Shares: 991,974.00 · Class: 0.5%
- BVF GP HOLDINGS LLC
Shares: 14,757,384.00 · Class: 6.9%
- BVF PARTNERS L P/IL
Shares: 16,000,000.00 · Class: 7.4%
- BVF INC/IL
Shares: 16,000,000.00 · Class: 7.4%
- LAMPERT MARK N
Shares: 16,000,000.00 · Class: 7.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002791
- Form type
- SCHEDULE 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Oct 22, 2025
- Reporting period
- Oct 15, 2025
- Description
- Schedule 13G beneficial ownership